Skip to main content

Table 1 GLIAS-III main inclusion and exclusion criteria

From: Glycemic variability: prognostic impact on acute ischemic stroke and the impact of corrective treatment for hyperglycemia. The GLIAS-III translational study

Inclusion criteria

Exclusion criteria

Male and female patients older than 18 years, with acute IS

Inclusion in the study within the first 24 h of stroke onset

A prestroke score on the Modified Rankin Scale (mRS) ≤ 1

Signed informed consent

Transient ischemic attack

Predicted need for an MRI within the first 96 h after inclusion

A health status, clinical condition or other characteristic that precludes appropriate diagnosis, treatment, or follow-up in the trial

Current drug or alcohol use dependence

Participation in a therapeutic clinical trial